Related Experiment Videos
Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor
1Department of Molecular Medicine, Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, 78245-3207, USA.
Abstract:
To assess biological roles of the retinoblastoma protein (RB), four independent transgenic mouse lines expressing human RB with different deletions in the N-terminal region (RBdeltaN) were generated and compared with mice expressing identically regulated, full-length RB. Expression of both RB and RBdeltaN caused developmental growth retardation, but the wild-type protein was more potent. In contrast to wild-type RB, the RBdeltaN proteins were unable to rescue Rb-/- mice completely from embryonic lethality. Embryos survived until gestational day 18.5 but displayed defects in the terminal differentiation of erythrocytes, neurons, and skeletal muscle. In Rb+/- mice, expression of the RBdeltaN transgenes failed to prevent pituitary melanotroph tumors but delayed tumor formation or progression. These results strongly suggest that N-terminal regions are crucial for embryonic and postnatal development, tumor suppression, and the functional integrity of the entire RB protein. Furthermore, these transgenic mice provide models that may begin to explain human families with low-penetrance retinoblastoma and mutations in N-terminal regions of RB.
Insights
The retinoblastoma protein's (RB) N-terminal regions are vital for development and tumor suppression. Deletions in these regions impair RB function, impacting embryonic development and increasing tumor risk.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- The retinoblastoma protein (RB) is a critical tumor suppressor.
- Understanding RB's specific functional domains is essential for comprehending its role in development and cancer.
Purpose of the Study:
- To investigate the biological roles of RB's N-terminal regions.
- To determine the impact of N-terminal deletions (RBdeltaN) on RB protein function in vivo.
Main Methods:
- Generation of four transgenic mouse lines expressing human RB with N-terminal deletions (RBdeltaN).
- Comparison of RBdeltaN mice with mice expressing full-length RB under identical regulation.
- Assessment of developmental impacts, embryonic lethality rescue, and tumor suppression efficacy.
Main Results:
- Expression of both RB and RBdeltaN caused growth retardation, with wild-type RB being more potent.
- RBdeltaN proteins could not fully rescue Rb-/- mice from embryonic lethality, with embryos surviving until E18.5.
- RBdeltaN expression failed to prevent pituitary melanotroph tumors in Rb+/- mice but delayed their progression.
- Defects in terminal differentiation of erythrocytes, neurons, and skeletal muscle were observed in RBdeltaN-expressing embryos.
Conclusions:
- RB's N-terminal regions are crucial for embryonic and postnatal development.
- These regions are essential for the tumor suppressive functions of RB.
- RB N-terminal deletions impact the protein's overall functional integrity.
- These findings provide models for human retinoblastoma with N-terminal RB mutations.